A Study of ICP-192 in Patients With Advanced Solid Tumors
Clinical trial NCT04565275 · UNKNOWN
Trial details
- NCT number
- NCT04565275
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2023-11-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.